Industry News
Pharmaceutical Industry News
Why aren’t diagnostic-driven…
Why aren’t diagnostic-driven therapies reaching enough patients?
Following a string of customer…
Following a string of customer complaints, a Form 483 and a recall this past spring, a Fresenius manufacturing unit in Utah is contending with a warning letter from the FDA.
The social media collaboration…
The social media collaboration ties into Novartis' "you know your MS best" messaging, which encourages patients to keep track of changes in their disease.
Two votes of confidence from…
Two votes of confidence from leaders at the FDA’s Office of Clinical Evaluation and the Oncology Center of Excellence sealed Replimune’s fate, overruling review staffers’ concerns and paving the way for last month’s accelerated nod
About two years ago, a…
About two years ago, a head-to-head progression-free survival win made Akeso and Summit’s ivonescimab—and the PD-1xVEGF class—the most promising agent to replace Keytruda. Now, that same trial has met its overall survival endpoint, but to
A Guide to Covid, Flu and R.S.V. Vaccines This Fall
Major medical groups released new recommendations on who should get the shots, citing a lack of strong guidance from the federal government.
The new business unit is centered…
The new business unit is centered on four core capabilities, which includes AI-enhanced scientific intelligence, omnichannel "scientific ecosystems," and more.
RNA-based vaccines and…
RNA-based vaccines and therapeutics may have faced a bumpy road in the U.S. recently, but a major new federal investment proves the government is still betting big on its future.
Novartis could cut about 130 jobs…
Novartis could cut about 130 jobs in Switzerland as it rethinks its biologics technical development and production footprint in Basel.
On the back of a heart-helping win…
On the back of a heart-helping win for the 11-year-old Repatha last fall, Amgen has continued to deepen the evidence on its PCSK9 inhibitor’s ability to cut cardiovascular risks in many patients.
Why are so many eligible patients…
Why are so many eligible patients still missing the therapies designed for them?
As part of the MFN drug pricing…
As part of the MFN drug pricing deal the Trump administration signed with obesity giants Eli Lilly and Novo Nordisk, Medicare recently launched a “bridge” model, offering weight loss drugs to eligible seniors at $50
After losing Bristol Myers Squibb…
After losing Bristol Myers Squibb as a client, Cellares continues to move forward with the right-sizing its CEO unveiled late last month.
TV outcomes company EDO determined…
TV outcomes company EDO determined that Galderma’s skin disease med Nemluvio led the charge with the highest engagement score across all advertisers during the 2025-26 NFL football season.
Ozempic Maker Novo Nordisk’s Investors Are Nervously Looking Into the Future
Novo Nordisk’s chief executive, Mike Doustdar, is a year into a corporate turnaround. He says investors are still underestimating the promise of the company’s drugs.
After pivoting from mobile gaming…
After pivoting from mobile gaming marketing to pharma, Genentech performance marketing engagement lead Tiffany William is making performance marketing "less daunting" and "more fun" and approachable.
Novartis appears to have broken…
Novartis appears to have broken the curse of the BTK inhibitor class. The Swiss pharma announced Tuesday that two phase 3 trials for Rhapsido in relapsing multiple sclerosis hit their goals without any liver safety
This podcast feature a fireside…
This podcast feature a fireside chat between Dr Ira Mellman, PICI and Dr Axel Hoos, Former CEO, Scorpion Therapeutics from the 2026 Immuno-Oncology 360° conference.
A new survey out from Bausch +…
A new survey out from Bausch + Lomb has shown that dry eye disease is one of the least recognized symptoms present in perimenopausal and postmenopausal women.
Emergent BioSolutions looks to…
Emergent BioSolutions looks to expand awareness and education of its Narcan opioid overdose reversal spray with an expanded campaign that kicked off on International Overdose Awareness Day.